<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Xenotherapeutics on Bioecon</title><link>https://en.bioecon.ru/companies/xenotherapeutics/</link><description>Recent content in Xenotherapeutics on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Fri, 03 Jul 2026 18:16:32 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/companies/xenotherapeutics/index.xml" rel="self" type="application/rss+xml"/><item><title>Xenotransplantation</title><link>https://en.bioecon.ru/technology/xenotransplantation/</link><pubDate>Fri, 03 Jul 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/xenotransplantation/</guid><description>Transplanting organs from multiplex gene-edited pigs into humans to address the chronic shortage of donor organs, now moving from expanded-access compassionate cases into FDA-cleared clinical trials.</description></item></channel></rss>